Case control study to identify risk factors for acute hepatitis C virus infection in Egypt

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Kandeel, Amr M ^a   Talaat, Maha ^b   Afifi, Salma A ^b   El Sayed, Nasr M ^a   Fadeel, Moustafa A A ^b   Hajjeh, Rana A ^c   Mahoney, Frank J ^c  

^a MINISTRY OF HEALTH   (Egypt)

^b US Naval Medical Research Unit No 3   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acute Hepatitis C; Egypt; Risk factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; INFUSION FLUID;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EGYPT; FEMALE; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRISONER; SURGERY; VIRUS TRANSMISSION;

EID: 84868648839     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-294     Document Type: Article

References (31)

1. World Health Organization Hepatitis C Fact sheet N°164 June 2011 2011, http://www.who.int/mediacentre/factsheets/fs164/en/., World Health Organization.
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567. 10.1016/S1473-3099(05)70216-4, 16122679.
3. Argentero PA, Zotti CM, Abbona F, et al. Regional surveillance of occupational percutaneous and mucocutaneous exposure to blood-borne pathogens in health care workers: strategies for prevention. Med Lav 2007, 98:145-155.
4. Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: A review of the literature. Epidemiol Infect 2002, 129:577-585. 10.1017/S0950268802007902, 2869920, 12558341.
5. Marx MA, Murugavel KG, Sivaram S, et al. The association of Health-care use and hepatitis C virus infection in a random sample of urban slum community residents in Southern India. Am J Trop Med Hyg 2003, 68:258-262.
6. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355:887-891. 10.1016/S0140-6736(99)06527-7, 10752705.
7. El-Zanaty F, Ann W. Egypt Demographic and Health Survey 2008 2009, Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International.
8. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A. The Epidemiology and Iatrogenic Transmission of Hepatitis C Virus in Egypt: A Bayesian Coalescent Approach. Mol Biol Evol 2003, 20:381-387. 10.1093/molbev/msg043, 12644558.
9. Klimashevskaya S, Obriadina A, Ulanova T, et al. Distinguishing Acute from Chronic and Resolved Hepatitis C Virus (HCV) Infections by Measurement of Anti-HCV Immunoglobulin G Avidity Index. J Clin Microbiol 2007, 45:3400-3403. 10.1128/JCM.01012-07, 2045353, 17715377.
10. Mohamed MK, Abdel-Hamid M, Mikhail NN, et al. Intrafamilial transmission of hepatitis C in Egypt. Hepatology 2005, 42:683-687. 10.1002/hep.20811, 16032698.
11. Saleh DA, Shebl F, Abdel-Hamid M, et al. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. Trans R Soc Trop Med Hyg 2008, 102:921-928. 10.1016/j.trstmh.2008.04.011, 18514243.
12. Perz J, Alter MJ. The coming wave of HCV-related liver disease: Dilemmas and challenges. J Hepatol 2006, 44:441-443. 10.1016/j.jhep.2005.12.007, 16426700.
13. Centers for Disease Control and Prevention, case definitions of diseases under public health surveillance 2007, http://www.cdc.gov/epo/dphsi/casedef/hepatitiscacutecurrent.htm., Centers for Disease Control and Prevention, case definitions of diseases under public health surveillance.
14. Sullivan KM, . OPEN EPI calculator available 2011, http://www.openepi.com/Menu/OpenEpiMenu.htm., OPEN EPI calculator available.
15. Morbidity and Mortality Weekly Report Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus 2003, Recommendations and Reports: Recommendations and Reports, Vol. 52 / No. RR-3. http://www.cdc.gov/mmwr/pdf/rr/rr5203.pdf., Morbidity and Mortality Weekly Report.
16. Medhat A, Shehata M, Magder LS, et al. Hepatitis C in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg 2002, 66:633-638.
17. Mohareb E, Soliman A, Aoun S, et al. Viral Hepatitis in a Bedouin population in the Sinai, Egypt 2002, 10-14. Denver, Colorado, USA: A cross sectional study. In: program and abstracts of the 51st Annual Meeting of the American Society of Tropical Medicine and Hygiene.
18. Forns M, Armelles R, Planas R, et al. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hepatol 2008, 48:20-27. 10.1016/j.jhep.2007.07.031, 17998149.
19. Maugat S, Astagneau P, Thibault V, et al. Nosocomial risk factors of hepatitis C infection- A multicenter study in a hospital-based population. Rev Epidemiol Sante Publique 2003, 51:301-308.
20. Karmochkine M, Carrat F, Santos OD, Cacoub P, Raquin G. A case control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat 2006, 13:775-782. 10.1111/j.1365-2893.2006.00742.x, 17052278.
21. Morbidity and Mortality Weekly Report (MMWR) Notice to Readers Recommendations for Follow-Up of Health-Care Workers After Occupational Exposure to Hepatitis C Virus. Morb Mortal Wkly Rep 1997, 46:603-606. Morbidity and Mortality Weekly Report (MMWR).
22. Bronowicki JP, Venard V, Botte C, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997, 337:237-240. 10.1056/NEJM199707243370404, 9227929.
23. Mele A, Spada E, Sagliocca L, et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol 2001, 35:284-289. 10.1016/S0168-8278(01)00111-8, 11580153.
24. Becheur H, Harzic M, Colardelle P, et al. Hepatitis C virus contamination of endoscopes and biopsy forceps. Gastroenterol Clin Biol 2000, 24:906-910.
25. Talaat M. el-Oun S, Kandeel A et al. Overview of injection practices in two governorates in Egypt. Trop Med Int Health 2003, 8:234-241. 10.1046/j.1365-3156.2003.01015.x, 12631314.
26. Karsenti D, Metman EH, Viguier J, et al. Transmission by colonoscopy of hepatitis C virus: a propos of a group of 97 patients at " presumed risk" . Gastroenterol Clin Biol 1999, 23:985-986.
27. Ciancio A, Manzini P, Castagno F, et al. Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus. Ann Intern Med 2005, 142:903-909.
28. Alter MJ. Prevention of spread of hepatitis C. J Hepatol 2002, 36:593-598.
29. Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003, 26:171-184. 10.1016/S1386-6532(02)00116-6, 12600649.
30. Dewing S, Plüddemann A, Myers BJ, Parry C. Review of injection drug use in six African countries: Egypt, Kenya, Mauritius, Nigeria, South Africa and Tanzania. Drugs Educ Prev Pol 2006, 13:121-137. No. 2.
31. Talaat M, Kandeel A, Rasslan O, et al. Evolution of infection control in Egypt: achievements and challenges. Am J Infect Control 2006, 34:193-200. 10.1016/j.ajic.2005.05.028, 16679176.